3.Tezacaftor, Ivacaftor- (Feb 2018)- to treat fibrosis in patient 12 yeas and older
Drug Name:
3.Tezacaftor, Ivacaftor- (Feb 2018)- to treat fibrosis in patient 12 yeas and older
List Of Brands:
Indication Type Description:
Indication:
U.S. FDA APPROVED DRUGS DURING 2018
Sr.No- 3
Name of the Drug- SYMDEKO
f
Active Ingredient - Tezacaftor,Ivacaftor
Pharmacological Classification-
To treat cystic fibosis in patients 12 years and older
Date of Approval- 2-12-2018